Targeting the Prohibitin Scaffold-Craf Kinase Interaction in RAS-ERK-driven Pancreatic Ductal Adenocarcinoma

Molecular Cancer - United Kingdom
doi 10.1186/1476-4598-13-38
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Metformin Restrains Pancreatic Duodenal Homeobox-1 (PDX-1) Function by Inhibiting ERK Signaling in Pancreatic Ductal Adenocarcinoma.

Current Molecular Medicine
BiochemistryMedicineMolecular MedicineMolecular Biology
2016English

Vav1 and Mutant K-Ras Synergize in the Early Development of Pancreatic Ductal Adenocarcinoma in Mice

Life Science Alliance
Plant ScienceEcologyGeneticsMolecular BiologyBiochemistryMutagenesisHealthToxicology
2020English

A Cholecystokinin B Receptor-Specific DNA Aptamer for Targeting Pancreatic Ductal Adenocarcinoma

Nucleic Acid Therapeutics
BiochemistryMolecular MedicineDrug DiscoveryGeneticsMolecular Biology
2017English

Molecular Targeting of Cell-Permeable Peptide Inhibits Pancreatic Ductal Adenocarcinoma Cell Proliferation

Oncotarget
Oncology
2017English

Non-Coding RNAs in Pancreatic Ductal Adenocarcinoma

Frontiers in Oncology
Cancer ResearchOncology
2020English

Pancreatic Ductal Adenocarcinoma With Cystic Features

HPB
HepatologyGastroenterology
2016English

Tumor-Stroma Interactions in Pancreatic Ductal Adenocarcinoma

Molecular Cancer Therapeutics
Cancer ResearchOncology
2007English

Targeting Multiple Effector Pathways in Pancreatic Ductal Adenocarcinoma With a GQuadruplex-Binding Small Molecule

English

The Characterization of “Islet Invasion” in Pancreatic Ductal Adenocarcinoma

HPB
HepatologyGastroenterology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy